Therefore, it is possible that in some contexts AHRR mechanisms may be predominant as opposed to PARP7-DTX2-mediated degradation of AHR, and this may at least in part explain why certain cancer cell lines are resistant to PARP7 inhibition (Gozgit et al, 2021). This evidence concerns the gene TIPARP and cancer.